Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Calliditas Therapeutics AB
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calliditas Therapeutics AB
Selling, General & Administrative Peer Comparison

Comparables:
CAMX
S
SECARE
IRLAB A
MOB
I
FLERIE

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Calliditas Therapeutics AB
STO:CALTX
Selling, General & Administrative
-kr1.3B
CAGR 3-Years
-74%
CAGR 5-Years
-95%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Selling, General & Administrative
-kr497.2m
CAGR 3-Years
-20%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Selling, General & Administrative
-kr387.9m
CAGR 3-Years
-80%
CAGR 5-Years
-72%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Selling, General & Administrative
-kr53.1m
CAGR 3-Years
-30%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Selling, General & Administrative
-kr24.9m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Selling, General & Administrative
-kr23.1m
CAGR 3-Years
-30%
CAGR 5-Years
-19%
CAGR 10-Years
N/A

See Also

What is Calliditas Therapeutics AB's Selling, General & Administrative?
Selling, General & Administrative
-1.3B SEK

Based on the financial report for Jun 30, 2024, Calliditas Therapeutics AB's Selling, General & Administrative amounts to -1.3B SEK.

What is Calliditas Therapeutics AB's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-95%

Over the last year, the Selling, General & Administrative growth was -36%. The average annual Selling, General & Administrative growth rates for Calliditas Therapeutics AB have been -74% over the past three years , -95% over the past five years .

Back to Top